Skip to main content
. 2022 Dec 22;17(1):45–54. doi: 10.21010/Ajidv17i1.4

Table 3.

Analysis of Preeclampsia Incidence in SARS-CoV-2 Infection.

Variable Case 1 Case 2 Case 3 Case 4 Case 5
age (years) 23 38 42 32 29
LILA (cm) 28.79 28.56 28.44 27.58 26.79
Gravida 1 3 3 1 2
parity 0 0 2 0 1
Abortion 0 2 0 0 0
co-morbidities Eisenmenger syndrome Preeclampsia Preeclampsia Preeclampsia Preeclampsia
Gestational age at termination (weeks) 30 30 38 28 36
Antigen_SARSCOV2 positive positive positive positive positive
SpO2 (%) 70% 70% 60% 70% 50%
Ventilator yes yes yes yes yes
HB (g/dl) 17.4 12.4 9.5 13.1 13.5
HT (%) 54 35 28.6 43.3 39.5
Leu (/ml) 38410 11390 7150 21510 10210
PLT (/ml) 356000 495000 157000 480000 246000
Neu Abs (%) 33.69 11.21 6.34 20.34 8.94
Lim Abs (%) 2.48 1.18 0.46 0.47 0.99
D-dimer (uL/ml) 903 583 583 1500 1140
Fibrinogen (mg/dl) 328 390 468 529 900
Symptom Hard Hard Critical Hard Critical
SGOT 25 26 30 53 19
SGPT 19 13 15 19 23
GDS (mg/dl) 101 267 138 584 82
urea 103 17 19 86 17
Creatinine 5 0.78 0.73 1.18 0.75
CRP 0.7 2.8 1.4 0.7 0.7
Thorax Photo BP BP BP BP BP
Length of Treatment 9 9 4 6 3
BBL (grams) 1000 1220 3345 1100 2855
Baby RT-PCR Negative Negative Negative Negative Negative
APGAR 2/3 3/4 8/9 0/0 8/9
Placenta Weight (grams) 469 479 526 426 497
Baby Output Death Death Life OF life
NBS 15 15 35 10 30
Baby hematology
 HB (g/dl) 9.6 8 12.9 11.3 17.4
 HT (%) 28 23.9 36.5 39.1 50.8
 Leu (/ml) 15180 7750 11300 45980 9060
 PLT (/ml) 43000 165000 314000 139000 8000
 Neu Abs (%) 9.94 2.86 8.33 44.85 4.88
 Lim Abs (%) 3.98 3.74 1.35 0.46 3.18
Baby Care Length 1 5 12 0 2
SARS-CoV-2 Placental Protein N Expression Negative Negative Negative Negative Negative